[Home][Profile][Hours][Directions][Map][Hospitals][Groups][Insurance][Payment][Contact][resume][Carl's cv][Calendar][Services][What's New]

[Resume]

[Dividing Line Image]

CURRICULUM VITAE

William F. Owen, Jr., M.D.

Office Address 45 Castro Street, Suite 402
San Francisco, California 94114-1027
Office Telephone 415.861.2400
Office Fax 415.861.8733
Website www.owenmed.com
E-mail bill@owenmed.com
Date of Birth February 24, 1949
Place of Birth Philadelphia, Pennsylvania
Citizenship U.S.

 

Education Central High School
Philadelphia, Pennsylvania
1961-1965
Bachelor of Arts Degree
Temple University
Philadelphia, Pennsylvania
1965-1969
Bachelor of Arts Degree cum laude, 1969
Temple University School of Medicine
Philadelphia, Pennsylvania
1969-1973
Doctor of Medicine, 1973
Baystate Medical Center
An Affiliate of Tufts University School of Medicine
Springfield, Massachusetts
Residency in Internal Medicine, 1973-1976
University of California San Francisco
San Francisco, California
Fellowship in Emergency Medicine, 1976-1978

 

Positions Held Coordinator of Emergency Medicine Education, 1978-1979
University of California San Francisco
San Francisco, California
Private Practice, 1979-present
Internal Medicine and HIV Medicine
San Francisco, California

 

Licensure and Certification Medical Licensure:
California G-031385
Specialty Certification: Internal Medicine
Diplomate, American Board of Internal Medicine, 1976
  Subspecialty Credentials: HIV Medicine
American Academy of HIV Medicine, 2001-200
9

 

Professional Associations American Medical Association
California Medical Association
San Francisco Medical Society
American College of Physicians
Union of American Physicians and Dentists
American Society of Microbiology
Infectious Diseases Society of America/HIV Medicine Association
International AIDS Society
American Academy of HIV Medicine
California Academy of HIV Medicine
Community Consortium of Bay Area AIDS Providers
Gay and Lesbian Medical Association
(formerly American Association of Physicians for Human Rights)
Bay Area Physicians for Human Rights
Founder: 1977
Secretary: 1977-1980
Member: 1977-present

 

Hospital Affiliations Active Staff
California Pacific Medical Center
Castro & Duboce Streets
San Francisco, California 94114
Courtesy Staff
St. Luke's Hospital
3555 Cesar Chavez Street
San Francisco, California 94110

 

Civic and Political Activities Human Rights Campaign Federal Club

 

Other Professional Activities Member of Board of Consulting Editors,
Journal of Homosexuality
1984 to present
Consultant to Task Force on AIDS,
California Medical Association
1982-1989
Member of AIDS Medical Advisory Committee,
Department of Public Health,
City and County of San Francisco

1986-1988

 

Honors and Awards In 1982, the University of California, San Diego designated the first clinic in the San Diego area to serve the health needs of gay and lesbian patients as "The Owen Clinic" in honor of William F. Owen, Jr., M.D.
On October 13, 1988, at its Annual Meeting in Atlanta, Georgia, the American Society of Internal Medicine named William F. Owen, Jr., M.D. as the recipient of its 1988 Special Recognition Award, in honor of his work with patients with human immunodeficiency virus.
In June, 2000, Bill was honored with the annual Gay Pride Community Service Award by San Francisco PBS affiliate KQED-TV.
  In January, 2004, Dr. Bill Owen was named by San Francisco Magazine as one of the best HIV/AIDS specialists in the San Francisco Bay Area.
  In January 2005, San Francisco Magazine named William F. Owen M.D. one of the top primary care physicians in the San Francisco Bay Area.
  In its Winter/Spring 2006 issue , Bay Area Consumers Checkbook named Dr. William Owen as one of the top-rated primary care physicians in the San Francisco Bay Area.

 

Publications: Peer Reviewed Journals

Owen WF Jr.
Sexually transmitted diseases and traumatic problems in homosexual men [Review].
Ann Intern Med. 1980 Jun;92(6):805-8.

Owen WF Jr.
The clinical approach to the homosexual patient.
Ann Intern Med. 1980 Jul;93(1):90-2.

McGhee RD, Owen WF Jr.
Medical aspects of homosexuality [letter].
N Engl J Med. 1980 Jul 3;303(1):50-1.

Bolan RK, Owen WF Jr, Owen RL.
Hepatitis B and sexual practices [letter].
Ann Intern Med. 1982 May;96(5):678.

Owen WF Jr.
Sexually transmitted diseases in the homosexual community.
Dermatol Clin North Am. 1983 Jan;1(1):123-9.

Owen WF Jr.
Medical problems of the homosexual adolescent.
J Adolesc Health Care. 1985 Jul;6(4):278-85.

Owen WF Jr.
The clinical approach to the male homosexual patient.
Med Clin North Am. 1986 May;70(3):499-535.

Bush RA Jr, Owen WF Jr.
Trauma and other noninfectious problems in homosexual men.
Med Clin North Am. 1986 May;70(3):549-66.

Owen WF Jr.
Preventing transmission of human immunodeficiency virus infection.
West J Med. 1988 Feb;148(2):198.

Blumenfeld W, Basgoz N, Owen WF Jr, Schmidt DM.
Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection.
Ann Intern Med. 1988 Sep 15;109(6):505-7.

Owen WF Jr.
Medical evaluation of the gay male patient.
In: Stults BM, Dere WH, eds.
Practical Care of the Ambulatory Patient.
Philadelphia: W.B. Saunders, 1989: 351-81.

Owen WF Jr.
The changing nature of medicine in the era of HIV.
In: Abrams D, Gottlieb M, Grieco M, eds.
AIDS/HIV Experimental Treatment Directory. 1989 Aug;3(2):42-5.
New York: American Foundation for AIDS Research.

Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Gordon SM, Owen WF Jr, Matthews Tr, Buhles WC, et al.
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection.
J Infect Dis. 1991 Apr; 163(4):716-719.

Stricker RB, Sanders KA, Owen WF, Kiprov DD, Miller RG.
Mononeuritis multiplex associated with cryoglobulinemia in HIV infection.
Neurology. 1992 Nov; 42(11):2103-2105.

Jacobson MA, Owen W, Campbell J, Brosgart C, Abrams DI.
Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS.
Clin Infect Dis. 1993 Feb; 16 Suppl 1():S69-73.

Lalezari JP, Drew WL, Glutzer E, Miner D, Safrin S, Owen WF Jr, Davidson JM, Fisher PE, Jaffe HS.
Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
J Infect Dis. 1994 Sep; 170(3):570-572.

Owen WF Jr.
Gay and bisexual men and medical care.
Chapter 41 in: Cabaj RP, Stein TS, eds.
Textbook of Homosexuality and Mental Health. 1996:673-86.
Washington, D.C.: American Psychiatric Press, Inc.

Berger D, Bucher G, Cimoch P, Nemechek P, Owen W, Steinhart C, Sullivan-Bolyai JZ.
Measurement of body weight and body cell mass in patients receiving highly active antiretroviral therapy (HAART).
Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, September 28-October 1, 1997, Abstract I-26

Owen WF Jr.
Antiretroviral therapies
In Tinkle JD, guest ed.
Clinics in Podiatric Medicine and Surgery. 1998:227-39.
Philadelphia: W.B. Saunders

Owen WF, Stein C.
Efficacy and durability of delavirdine in pharmacokinetic enhancement of protease inhibitors for AIDS patients with extensive antiretroviral therapy (ART) experience.
Abstracts of the XIII International AIDS Conference
Durban, South Africa, July 9-14, 2000, Abstract WePeB4162

Schutz MR, Owen WF
Multi-center analysis of delavirdine as a pharmacokinetic enhancer in HIV infected adults with extensive prior HIV treatment.
Program and Abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America
New Orleans, Louisiana, September 7-10, 2000, Abstract 350

Owen WF, Stein C.
Delavirdine combined with protease inhibitors: durability and efficacy for salvage therapy in AIDS.
Program and Abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America
San Francisco, California, October 25-28, 2001, Abstract 679

Owen Jr, WF, Chamberlain L, Warren DR, Ebrahimi R, Flaherty JF, Dong BJ.
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/r) in HIV-infected adults.
Program and Abstracts of the 3rd International AIDS Society Conference on Pathogenesis and Treatment
Rio de Janeiro, Brazil, July 24-27, 2005, Abstract WePe6.3C10

Owen Jr, WF, Chamberlain L, Warren DR, Ebrahimi R, Dong BJ, Flaherty JF.
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/RTV) in HIV-infected adults.
Program and Abstracts of the 10th European AIDS Conference / EACS,
Dublin, Ireland, November 17-20, 2005, Abstract PE 7.3/6

Owen W, Chamberlain L, Warren D, Ebrahimi R, Dong B, Flaherty J.
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/r) in HIV-infected adults.
Program and Abstracts of the 15th Annual Canadian Conference on HIV/AIDS Research
Quebec City, Canada, May 25-28, 2006, Abstract 232P

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group
CD4+ Count-Guided Interruption of Antiretroviral Treatment.
N Engl J Med. 2006 Nov 30;355(22):2283-96.

Financial Disclosure

Grants/Research Support None
Consultant/Honoraria Auxilium
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Merck
Pfizer
Roche
Speakers' Bureau Auxilium
Boehringer-Ingelheim
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Roche
Tibotec
Stock Shareholder
(directly purchased)
Amgen
Johnson & Johnson
Merck
Wyeth

[Home][Profile][Hours][Directions][Map][Hospitals][Groups][Insurance][Payment][Contact][resume][Carl's cv][Calendar][Services][What's New]

Send mail to bill at owenmed dot com with questions or comments.
Last modified: March 31, 2008